Clinical trial
Efficacy of the Endocardial Stem Cells Implantation in Ischemic Heart Failure Patients
NCT00841958 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the Endocardial Stem Cells Implantation in Ischemic Heart Failure Patients
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- December 31, 2011
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.